The P & T Committee at Trinity Lutheran Hospital, a 320-bed, community
/teaching hospital in Kansas City, MO, has developed dosing and monito
ring guidelines for foscarnet sodium (Foscavir) and trimetrexate glucu
ronate (Neutrexin)-two drugs used to treat patients with opportunistic
infections associated with the human immunodeficiency virus (HIV). Pr
esented in this Experience Brief is a short discussion of these drugs,
the rationale for guideline development, and the actual dosing and mo
nitoring protocols devised.